Maryland Clinic Begins Administering FDA-Approved CAR T-Cell Therapy for Blood Cancers

The Center for Cancer and Blood Disorders has received authorization to administer FDA-approved CAR T-cell therapy, marking a significant development in cancer treatment accessibility. The clinic, located in Maryland, has already begun treating its first patient with this advanced immunotherapy within a community oncology setting.

CAR T-cell therapy is a cutting-edge treatment that involves reprogramming a patient’s own immune cells to target and destroy cancer cells. This marks the first time such therapy has been made available at the community level in the Maryland area, expanding access beyond larger academic medical centers. The authorization allows the center to offer this innovative option to eligible patients battling certain types of blood cancers, including lymphoma and leukemia.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 23, 2026

Author

GOAI